Cytokinetics, Incorporated (CYTK)
CYTK price $62.86 -1.09 -1.70%
- Ticker
- CYTK
- Price
- $62.86
- Change
- -1.09 -1.70%
- Market cap
- $8.74B
- P/E
- -8.87
- Forward P/E
- 86.11
- Sector
- Healthcare
- Industry
- Biotechnology
- Stocklytics score
- 50
Cytokinetics, Incorporated, a biopharmaceutical company, focuses on discovering, developing, and commercializing novel muscle activators and muscle inhibitors as potential treatments for debilitating diseases in the United States. The company markets MYQORZO, a novel, oral, and small molecule cardiac myosin inhibitor for the treatment of symptomatic oHCM. It also develops Aficamten, a novel, oral, and small molecule…